We will outline some common GLP-1RAs, including liraglutide, exenatide, dulaglutide, and lixisenatide, along with their efficacy and limitations regarding cognitive function as observed in clinical trials (Table 1)
Results Patient Characteristics Of 16 058 identified patients who initiated a GLP-1 RA, 14 606 did not have cirrhosis and 1452 had cirrhosis at baseline
Notably, STZ-treated animals exhibit alterations in mitochondrial dynamics, including increased expression of fission proteins such as Drp1 and Fis1, accompanied by decreased levels of fusion-related proteins like Mfn2 and OPA1, particularly in the hippocampus and in the prefrontal cortex (Paidi et al., 2015
The Precision Peptide Genetic Test analyzes variants in GLP1R (rs6923761), GIPR (rs1800437), MC4R (rs17782313), and FTO (rs9939609)genes that influence appetite regulation, medication responsiveness, and genetic predisposition to weight regain
Madison Brooks, Teacher (US)
Conclusion GLP-1 agonists have revolutionized weight loss with effective, science-backed solutions